NewsBenzingaWave Life Sciences avvia lo studio clinico di fase 2a di WVE-007 per trattare l'obesità Wave Life Sciences avvia lo studio clinico di fase 2a di WVE-007 per trattare l'obesità Benzinga 2026.09.23 11:30 (GMT+0) Open on Benzinga Other news Baird Maintains Neutral on AutoZone, Lowers Price Target to $3400 UBS Initiates Coverage On Hut 8 with Buy Rating, Announces Price Target of $143 Guggenheim Reiterates Buy on Fox, Maintains $85 Price Target IM Cannabis Announces $1.31M Registered Direct Offering Of 655,000 Common Shares At A Price Of $2/Share Guggenheim Maintains Buy on Compass Therapeutics, Lowers Price Target to $4 UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24
IM Cannabis Announces $1.31M Registered Direct Offering Of 655,000 Common Shares At A Price Of $2/Share
